Home LiteratureArticle Details
PMID: 12610158 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.

Journal of virology ·Vol. 77 ·No. 6 ·2003-03-00 ·Pages 3832-7

Suphaphiphat P, Thitithanyanont A, Paca-Uccaralertkun S, Essex M, Lee TH

Abstract

The V3 loop and the bridging sheet domain of human immunodeficiency virus type 1 (HIV-1) subtype B envelope glycoprotein gp120 have been implicated in CCR5 coreceptor utilization. In this study, mutant envelope glycoproteins of a subtype C isolate containing substitutions in the V3 or C4 region were generated to determine which are required for efficient CCR5-dependent cell fusion and viral entry. We found that the V3 crown and C4 residues are relatively dispensable for cell-cell fusion, although some residues may be involved in the regulation of early postentry steps in viral replication. In contrast, seven highly conserved residues located in the V3 stem are critical for CCR5 utilization, which can explain the apparent paradox that the functional convergence in CCR5 usage by genetically divergent HIV-1 strains involves a variable region. The finding that C4 residues do not have a critical role may appear to contradict the current model that bridging sheet residues are involved in the gp120-CCR5 interaction. However, a plausible interpretation is that these C4 residues may have a distinct role in the binding and fusion steps of the gp120-CCR5 interaction.

MeSH Terms
Amino Acid Sequence Amino Acid Substitution Cell Fusion Cell Line DNA, Viral/metabolism HIV Envelope Protein gp120/chemistry,genetics,metabolism HIV-1/genetics,metabolism,pathogenicity Humans Peptide Fragments/chemistry,genetics,metabolism Proviruses Receptors, CCR5/metabolism Recombinant Fusion Proteins/metabolism Virion/metabolism Virus Integration
Chemicals
DNA, Viral HIV Envelope Protein gp120 HIV envelope protein gp120 (305-321) Peptide Fragments Receptors, CCR5 Recombinant Fusion Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Suphaphiphat Pirada
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Thitithanyanont Arunee
Paca-Uccaralertkun Saowakon
Essex Max
Lee Tun-Hou
References (30)
30 references, click to expand
  1. N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection.
    AIDS Res Hum Retroviruses. 2001 Nov 1;17(16):1473-9 PMID: 11709091
  2. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
    J Virol. 2001 Jun;75(12):5541-9 PMID: 11356961
  3. Role of nucleotide sequences in the V3 region in efficient replication of CCR5-utilizing human immunodeficiency virus type 1 in macrophages.
    Virology. 2002 Aug 1;299(2):192-203 PMID: 12202222
  4. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.
    Science. 1985 Dec 20;230(4732):1350-4 PMID: 2999980
  5. Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
    Gene. 1989 Apr 15;77(1):51-9 PMID: 2744487
  6. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    AIDS. 1990 Apr;4(4):297-305 PMID: 2190604
  7. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    J Virol. 1991 Jan;65(1):356-63 PMID: 1985204
  8. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    J Virol. 1993 Aug;67(8):4557-65 PMID: 8331723
  9. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    J Virol. 1994 Sep;68(9):5411-22 PMID: 8057423
  10. Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1.
    Virology. 1996 Mar 15;217(2):613-7 PMID: 8610455
  11. Identification of a major co-receptor for primary isolates of HIV-1.
    Nature. 1996 Jun 20;381(6584):661-6 PMID: 8649511
  12. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Science. 1996 Jun 28;272(5270):1955-8 PMID: 8658171
  13. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
    Cell. 1996 Aug 9;86(3):367-77 PMID: 8756719
  14. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
    Nature. 1996 Nov 14;384(6605):179-83 PMID: 8906795
  15. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
    Nature. 1996 Nov 14;384(6605):184-7 PMID: 8906796
  16. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.
    J Virol. 1997 Sep;71(9):6305-14 PMID: 9261347
  17. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.
    J Virol. 1997 Sep;71(9):7136-9 PMID: 9261451
  18. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
    Proc Natl Acad Sci U S A. 1998 May 12;95(10):5740-5 PMID: 9576954
  19. Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion.
    FEBS Lett. 1998 Apr 24;426(3):367-72 PMID: 9600268
  20. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
    Science. 1998 Jun 19;280(5371):1949-53 PMID: 9632396
  21. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
    Nature. 1998 Jun 18;393(6686):648-59 PMID: 9641677
  22. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function.
    J Biol Chem. 1999 Apr 2;274(14):9617-26 PMID: 10092648
  23. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4558-62 PMID: 10200301
  24. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    AIDS Res Hum Retroviruses. 1999 May 20;15(8):731-43 PMID: 10357469
  25. HIV and SIV gp120 binding does not predict coreceptor function.
    Virology. 1999 Jul 5;259(2):267-73 PMID: 10388651
  26. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.
    J Virol. 1999 Aug;73(8):6271-81 PMID: 10400718
  27. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    J Virol. 1999 Dec;73(12):10346-58 PMID: 10559353
  28. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.
    AIDS Res Hum Retroviruses. 2000 May 20;16(8):741-9 PMID: 10826481
  29. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    J Biol Chem. 2000 Oct 27;275(43):33516-21 PMID: 10938094
  30. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    J Virol. 2002 Sep;76(17):8953-7 PMID: 12163614
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-03-00
Pages
3832-7
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC149532
Subset
IM
Grants
FIC NIH HHS · D43 TW000004 · United States
FIC NIH HHS · TW00004 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com